893
Views
12
CrossRef citations to date
0
Altmetric
Editorials

Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines

, , , , &
Article: 32397 | Received 25 May 2016, Accepted 25 May 2016, Published online: 16 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Silvan R. Urfer, Caitlin S. Latimer, Warren Ladiges, C. Dirk Keene, Sarah Benbow, Benjamin Harrison, Daniel E.L. Promislow, Matt Kaeberlein, Brian C Kraemer, Adrienne Wang, Franco Guscetti & Martin Darvas. (2019) Cross species application of quantitative neuropathology assays developed for clinical Alzheimer’s disease samples. Pathobiology of Aging & Age-related Diseases 9:1.
Read now
Kavita Sharma, Martin Darvas, C. Dirk Keene, Laura J. Niedernhofer & Warren Ladiges. (2018) Modeling Alzheimer’s disease in progeria mice. An age-related concept. Pathobiology of Aging & Age-related Diseases 8:1.
Read now

Articles from other publishers (10)

Brianna Gurdon & Catherine Kaczorowski. (2021) Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models. Neurobiology of Disease 161, pages 105558.
Crossref
Asiamah Ernest Amponsah, Ruiyun Guo, Desheng Kong, Baofeng Feng, Jingjing He, Wei Zhang, Xin Liu, Xiaofeng Du, Zhenhuan Ma, Boxin Liu, Jun Ma & Huixian Cui. (2021) Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease . Reviews in the Neurosciences 32:4, pages 379-402.
Crossref
Michael S. Stringer, Hedok Lee, Mikko T. Huuskonen, Bradley J. MacIntosh, Rosalind Brown, Axel Montagne, Sarah Atwi, Joel Ramirez, Maurits A. Jansen, Ian Marshall, Sandra E. Black, Berislav V. Zlokovic, Helene Benveniste & Joanna M. Wardlaw. (2020) A Review of Translational Magnetic Resonance Imaging in Human and Rodent Experimental Models of Small Vessel Disease. Translational Stroke Research 12:1, pages 15-30.
Crossref
Christiana Bjorkli, Axel Sandvig & Ioanna Sandvig. (2020) Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients. Frontiers in Aging Neuroscience 12.
Crossref
Athanasios Metaxas, Camilla Thygesen, Stefan J. Kempf, Marco Anzalone, Ramanan Vaitheeswaran, Sussanne Petersen, Anne M. Landau, Hélène Audrain, Jessica L. Teeling, Sultan Darvesh, David J. Brooks, Martin R. Larsen & Bente Finsen. (2019) Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer’s disease. Scientific Reports 9:1.
Crossref
Ji Soo Lee, Yeunkum Lee, Emily A. André, Kea Joo Lee, Thien Nguyen, Yang Feng, Nuo Jia, Brent T. Harris, Mark P. Burns & Daniel T. S. Pak. (2019) Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer’s disease model mice. PLOS ONE 14:7, pages e0219691.
Crossref
Dafina M. AngelovaDavid R. Brown. (2018) Altered Processing of β-Amyloid in SH-SY5Y Cells Induced by Model Senescent Microglia. ACS Chemical Neuroscience 9:12, pages 3137-3152.
Crossref
Jennifer M. Pocock & Thomas M. Piers. (2018) Modelling microglial function with induced pluripotent stem cells: an update. Nature Reviews Neuroscience 19:8, pages 445-452.
Crossref
Gérard N. Bischof, Heike Endepols, Thilo van Eimeren & Alexander Drzezga. (2017) Tau-imaging in neurodegeneration. Methods 130, pages 114-123.
Crossref
John G. Moffat, Fabien Vincent, Jonathan A. Lee, Jörg Eder & Marco Prunotto. (2017) Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nature Reviews Drug Discovery 16:8, pages 531-543.
Crossref